Boehringer Ingelheim
Di Feng is a Senior Principal Scientist in Computational Biology at Boehringer Ingelheim, where expertise includes bioinformatics, system immunology, disease positioning, biomarker discovery, and translational science, with tenure starting in November 2013. Prior to this role, Di Feng served as a Scientist in Informatics and Genomics at University Hospital, UMDNJ, from 2006 to 2013, focusing on immunology, pathology, and next-generation sequencing (NGS). Di Feng earned a Ph.D. in Immunology and Pathology from Rutgers University - Newark between 2000 and 2006, with further education at Shanghai Jiao Tong University.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.